Best Practices in Lymph Node Mapping and Localization: Melanoma

Slides:

Advertisements

Similar presentations

H. AlHussain, I. Busca, L. Eapen,, S. El-Sayed The Ottawa Hospital Cancer Center, University of Ottawa Department of Radiation Oncology.

Advertisements

Frank P. Dawry LYMPHOSCINTIGRAPHY Sentinel node localization in Melanoma.

Indications for adjuvant radiation therapy with or without lymph nodes in salivary gland cancer Claus Rödel Department of Radiation Therapy University.

Sentinel Lymph Node Biopsy in Melanoma

Breast Cancer Tumor Board Chair Harold Burstein, MD, PhD Faculty Jennifer Bellon, MD Mehra Golshan, MD.

Suspicious axillary / groin lymph node diagnostic pathway Dr P Holloway 1.

Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.

A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.

Phase I Study of PLX4032: Proof of Concept for V600E BRAF Mutation as a Therapeutic Target in Human Cancer Flaherty K et al. American Society of Clinical.

How are Auckland Surgeons Managing the Axilla? E Whineray Kelly, O Pellet, L Neave, J Harman, R Harman. Auckland Breast Cancer Study Group.

Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.

The Neck Jochen A. Werner Marburg, Germany. The Neck in squamous cell carcinoma (HNSCC) in cancer of unknown primary in skin cancer in salivary gland.

Understanding Cancer and Related Topics

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Cancer: Staging and Grading What is meant by the term “biopsy”? How do tumors behave differently from one another ? Examples of the stages of cancer and.

Squamous Cell Carcinoma

Immune Keytruda.

Summary of staging criteria for cancers of the oral cavity, oropharynx, hypopharynx, and larynx. Carcinoma in situ is stage 0, and presence of distant.

By Caitlin Feeney January 5, 2010

Schema of the NSABP B-34 trial evaluating adjuvant oral clodronate in patients with resected stage I and II operable breast cancer (Chemo, adjuvant chemotherapy;

Advancing Care Forward in Squamous Cell Carcinoma of the Head and Neck

Fig. 2. Cervical lymph node metastasis in a 78-year-old woman

Evolving Standards in HER2-Targeted Adjuvant Therapy for Breast Cancer

Copyright © 2003 American Medical Association. All rights reserved.

Evolving Paradigms in Recurrent/Metastatic SCCHN

Perspectives on Triple-Negative Breast Cancer

Thrombosis, Cancer, and NOACs

Expert Perspectives on Clinically Challenging Cases in Narcolepsy

Does One Size Fit All in Obesity Management?

Discussion Outline Cells of the Immune System.

Progression After Cancer Immunotherapy in Advanced NSCLC

سرطان الثدي Breast Cancer

Introduction to Checkpoint Inhibitors

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

Neoadjuvant Therapy in HER2-Positive Breast Cancer

Shanthi Marur, MD, Arlene A. Forastiere, MD Mayo Clinic Proceedings

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Oral Anticoagulants in AFa,b A Brief History.

Introduction. For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers.

Managing gBRCA-Positive Metastatic Breast Cancer

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.

More Than Meets the Eye.

Case Studies in Unresectable Hepatocellular Carcinoma

Essential Concepts in the Use of Immunotherapies in Bladder Cancer

Immunotherapy for cSCC

SWAG SSG Skin Cancer Meeting

How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

The Road to Quality Improvement in HER2-Positive Breast Cancer

Cancer-Associated Thrombosis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

The Changing Field of Melanoma: Ipilimumab.

Patient-Centered Management in Advanced Non-Small Cell Lung Cancer

Lymphatic versus Hematogenous Melanoma Metastases: Support for Biological Heterogeneity without Clear Clinical Application Gyulnara G. Kasumova, Alex.

From Adjuvant to Metastatic in Melanoma

Multidisciplinary Management in Non-Small Cell Lung Cancer (NSCLC)

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

AMD Therapy: Where Are We Now and Where Are We Going?

Checkpoint Inhibitors in First-Line Advanced NSCLC

Clinical Considerations in the Use of Checkpoint Inhibitors Breast Cancer.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.

Immune profiling of patient-derived organotypic tumor spheroids.

Presentation transcript:

Best Practices in Lymph Node Mapping and Localization: Melanoma

Lymph Node Mapping in Melanoma

MSLT-I

MSLT-II Trial

Types of Radiotracers

Pearls for Practice

Best Practices in Lymph Node Mapping and Localization: Breast Cancer

Lymph Node Mapping in Breast Cancer

ACOSOG Z11 Trial: Practice-Changing Results

In Which Patients Can SLN Resection Be Omitted?

How Is SLN Mapping Performed?

Factors to Consider When Selecting a Mapping Agent

Additional Considerations

Best Practices in Lymph Node Mapping and Localization: Head and Neck Cancer

Lymph Node Mapping in Head and Neck Cancer

SLN Results and Adjuvant Treatment for T1-2 N0 Cancer of the Oral Cavity

Phase 2 Trial

SENT Trial

Pearls for Practice

Pearls for Practice (cont)

Phase 3 Trial of Tilmanocept in SLN Biopsy in Oral Squamous Cell Carcinoma

Abbreviations